Pharmaceutical

From Davids to Goliaths: the GLP-1RA gold rush

There are now more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.

Jan 4, 2025 - 06:00
From Davids to Goliaths: the GLP-1RA gold rush
There are now more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.
Read the original article

Tags:

Previous Article

IIT Guwahati and Bose Institute develop injectable hydrogel for cancer

Next Article

SIGA’s antiviral approved in Japan for orthopoxvirus treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Bristol drug reduces reliance on transfusions for people with chronic blood disorder

STAT+: Bristol drug reduces reliance on transfusions fo...

May 25, 2023

Eculizumab biosimilar by Turgut Ilaclari for Neuromyeli...

Jul 1, 2023

Key opinion leaders on unmet needs in amyotrophic lateral sclerosis

Key opinion leaders on unmet needs in amyotrophic later...

Jun 2, 2024